Skip to main content
Quest Diagnostics

A Large Reference Laboratory’s Experience Transitioning from Immunofixation to Immunotyping for Monoclonal Protein Detection

ADLM 2025

Association for Diagnostics and Laboratory medicine

Chicago, IL, July 27-31 , 2025

Poster presentation: A Large Reference Laboratory’s Experience Transitioning from Immunofixation to Immunotyping for Monoclonal Protein Detection

Authors: Mullins K

Medical Specialty: Oncology, Hematology, Immunology, Laboratory medicine, 

Related content

Audio Podcast
Enhancing Cancer Treatment Decisions With Ultrasensitive MRD Testing
On-Demand Webinar
Hemepath Master Class Myeloid Neoplasms MPN MDS AML
Publication
Effect of Digital Health Coaching on Self-Efficacy and Patient-Reported Outcomes in Individuals with Acute Myeloid and Chronic Lymphocytic Leukemia: A Pilot Randomized Controlled Trial
Conference Presentation
Evaluating Patient-Reported Outcomes and Wearable Data among Individuals with Relapsed/Refractory Multiple Myeloma
Publication
Randomized Phase 2 Study of Digital Life Coaching During Transplantation for Myeloma

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2025 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.